Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
BCPC 
Balchem Corporation (BCPC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: BCPC (1-star) is a SELL. SELL since 3 days. Simulated Profits (-6.40%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $200.33
1 Year Target Price $200.33
| 0 | Strong Buy |
| 2 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -13.89% | Avg. Invested days 39 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.98B USD | Price to earnings Ratio 35.19 | 1Y Target Price 200.33 |
Price to earnings Ratio 35.19 | 1Y Target Price 200.33 | ||
Volume (30-day avg) 2 | Beta 0.93 | 52 Weeks Range 145.70 - 184.99 | Updated Date 09/17/2025 |
52 Weeks Range 145.70 - 184.99 | Updated Date 09/17/2025 | ||
Dividends yield (FY) 0.56% | Basic EPS (TTM) 4.36 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 14.48% | Operating Margin (TTM) 20.3% |
Management Effectiveness
Return on Assets (TTM) 7.66% | Return on Equity (TTM) 11.99% |
Valuation
Trailing PE 35.19 | Forward PE 30.67 | Enterprise Value 5121850261 | Price to Sales(TTM) 5.05 |
Enterprise Value 5121850261 | Price to Sales(TTM) 5.05 | ||
Enterprise Value to Revenue 5.19 | Enterprise Value to EBITDA 21.15 | Shares Outstanding 32455200 | Shares Floating 32283505 |
Shares Outstanding 32455200 | Shares Floating 32283505 | ||
Percent Insiders 0.37 | Percent Institutions 90.95 |
Upturn AI SWOT
Balchem Corporation
Company Overview
History and Background
Balchem Corporation was founded in 1967. Initially focused on encapsulation technology, it has grown through innovation and acquisitions to become a global leader in specialty ingredients.
Core Business Areas
- Human Nutrition & Health: This segment develops, manufactures, and markets products that provide nutritional benefits to humans, including chelated minerals and specialty nutrients for dietary supplements and food fortification. It caters to consumer dietary and health trends.
- Animal Nutrition & Health: This segment offers products that improve animal health and productivity, including encapsulated feed ingredients, choline chloride, and other nutritional supplements for dairy, poultry, swine, and other livestock. Balchem helps to improve animal health and performance, which leads to greater output.
- Specialty Products: This segment encompasses products used in various industrial and agricultural applications, including ethylene oxide derivatives, performance additives for oil and gas, and plant nutrition products. This segment enables customers in various industries to achieve superior results.
Leadership and Structure
Ted Harris serves as the Chairman, President, and CEO. The company has a structured organizational framework that aligns the above-mentioned business segments.
Top Products and Market Share
Key Offerings
- Chelated Minerals (Human Nutrition): These minerals are designed for improved absorption in humans. Market share is estimated to be around 20% in the chelated mineral supplements market. Competitors include Albion Minerals (part of Balchem now) and other specialty mineral producers. Balchem is also a leading producer of chelated minerals.
- REA Shure (Dairy Nutrition): REA Shure is an encapsulated choline product for dairy cows that supports milk production and animal health. Balchem has significant market share within the choline encapsulation market, estimated over 50%. Competitors include other feed additive companies like ADM and Cargill that develop choline and rumen-protected choline products for animal consumption. Balchem has a reputation for high quality and research-backed science.
- Ethylene Oxide Derivatives (Specialty Products): Balchem produces ethylene oxide derivatives used in various industrial applications. Market share is dependent on the specific derivative and end-market application. Competitors include large chemical companies like Dow and BASF.
Market Dynamics
Industry Overview
The specialty ingredients market is growing, driven by increasing consumer awareness of nutrition, demand for healthier animal feed, and innovation in industrial applications.
Positioning
Balchem is a leader in specialty ingredients, with a strong focus on innovation and science-backed solutions. It differentiates itself through its encapsulation technology and focus on high-value applications. Its competitive advantages are in its differentiated solutions and market expertise.
Total Addressable Market (TAM)
The global specialty ingredients market is estimated to be over $200 billion. Balchem is positioned to capture a growing share of this market through innovation, strategic acquisitions, and expansion into new geographies.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Innovative product portfolio
- Diversified business segments
- Experienced management team
- Global presence
- High levels of technical expertise.
Weaknesses
- Exposure to commodity price fluctuations
- Dependence on key suppliers
- Potential for regulatory changes affecting products
Opportunities
- Expansion into emerging markets
- Acquisition of complementary businesses
- Development of new products and applications
- Increasing demand for sustainable and healthy ingredients
Threats
- Intense competition
- Economic downturn
- Changes in consumer preferences
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- DSM (DSM.AS)
- ADM (ADM)
- Cargill (Private)
- Ingredion (INGR)
Competitive Landscape
Balchem differentiates itself through its encapsulation technology and focus on high-value applications. It competes with larger companies on price and distribution, but its focus on innovation and customer service provides a competitive advantage.
Major Acquisitions
Albion Minerals
- Year: 2016
- Acquisition Price (USD millions): 370
- Strategic Rationale: The acquisition of Albion Minerals expanded Balchem's portfolio of chelated minerals and strengthened its position in the human nutrition market.
Growth Trajectory and Initiatives
Historical Growth: Balchem has achieved consistent revenue and earnings growth over the past decade, driven by organic growth and strategic acquisitions.
Future Projections: Analysts predict continued growth for Balchem, driven by increasing demand for its products and services. Revenue growth is projected to be in the high single digits.
Recent Initiatives: Recent initiatives include the acquisition of companies to expand into new markets and product categories, as well as investments in research and development to drive innovation.
Summary
Balchem is a strong company with a history of growth and innovation in the specialty ingredients market. Its diversified business segments and strong competitive advantages position it well for continued success. It needs to be aware of the current economic outlook and competitor's strategies.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Analyst Reports
- Market Research Reports
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market conditions and company performance may change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Balchem Corporation
Exchange NASDAQ | Headquaters Montvale, NJ, United States | ||
IPO Launch date 1986-06-03 | CEO, President & Chairman Mr. Theodore Lee Harris | ||
Sector Basic Materials | Industry Specialty Chemicals | Full time employees 1364 | Website https://www.balchem.com |
Full time employees 1364 | Website https://www.balchem.com | ||
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.